Anxiety and Depression Among Gendarmes Posted to French Guiana (TAD-GENDGF)

Anxiety and Depression Among Gendarmes Posted to French Guiana (TAD-GENDGF)

This is a mixed-method, single-center study involving two concurrent phases: a quantitative phase with an anonymous self-administered questionnaires, and a qualitative phase with individual contextual interviews and a focus group. The hypothesis underlying this study is that isolated postings are a risk factor for anxiety-depressive disorders. The aim of this study is to provide new information to help propose targeted prevention and health promotion measures.

Study Overview

• Status: Not yet recruiting
• Conditions: Anxiety Depression Disorder
• Intervention / Treatment: Other: Survey

• Study Type: Observational
• Enrollment (Estimated): 600

Contacts and Locations

• Study Contact: Name: DIA; Phone Number: 0594395983; Email: aissata.dia@intradef.gouv.fr

Study Locations

• French Guiana
  • Guyane
    • Cayenne, Guyane, French Guiana, 97306
      • DIASS Guyane
      • Contact: DIA; Phone Number: 0594395983

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

healthy volunteer

Description

Inclusion Criteria:

• Gendarme in active position
• Age over 18
• Assignment in French Guiana for more than 6 months at the time of the study
• Not opting for study participation

Exclusion Criteria:

• Previously diagnosed psychiatric condition
• People with a reading/writing disability in the French language
• Major incapacity

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of anxiety-depressive disorders according to posting site.	Comparison of the prevalence of anxiety-depressive disorders among gendarmes posted to French Guiana according to their posting site.	Through study completion (6 months)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Factors associated with the presence of an anxiety-depressive disorder	Evaluate factors associated with the presence of an anxiety-depressive disorder, both overall and by type of disorder	Through study completion (6 months)

Collaborators and Investigators

• Sponsor: Direction Centrale du Service de Santé des Armées

Study record dates

Study Major Dates

• Study Start (Estimated): November 1, 2023
• Primary Completion (Estimated): October 1, 2024
• Study Completion (Estimated): November 1, 2024

Study Registration Dates

• First Submitted: October 26, 2023
• First Submitted That Met QC Criteria: October 31, 2023
• First Posted (Actual): November 1, 2023

Study Record Updates

• Last Update Posted (Actual): November 1, 2023
• Last Update Submitted That Met QC Criteria: October 31, 2023
• Last Verified: October 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Mental Disorders; Mood Disorders; Depression; Depressive Disorder; Anxiety Disorders
• Other Study ID Numbers: 2022PPRC07; 2023-100889-36 (Other Identifier: IDRCB)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No